Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31673503 | 1.00 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL29633172 | 1.00 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL19922315 | 1.00 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL17627695 | 1.00 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL721372 | 1.00 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL9238452 | 1.00 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL9381726 | 0.73 | MAPK1 (0.33) | — | |
| SCHEMBL9639468 | 0.72 | — | — | |
| SCHEMBL9506330 | 0.72 | — | — | |
| SCHEMBL17691143 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | claimed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| EP-4218837-B1 | VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH & CIE (CH) | 2024-11-27 | — | — | EP | disclosed |
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | FIRMENICH SA (CH) | 2023-09-05 | — | — | US | disclosed |
| EP-3541435-B1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH & CIE (CH) | 2023-08-30 | — | — | EP | disclosed |
| EP-4218837-A1 | VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | Firmenich SA (CH) | 2023-08-02 | — | — | EP | disclosed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | disclosed |
| CN-111432851-B | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | TAS2R8, TRPA1, TAS2R10 | CA1 4530/4885CA2 1444/4885CA4 1031/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | CA1 4530/4885CA2 1444/4885CA4 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.